|
MLL2 expression based on
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.881800E-01 |
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 4 samples. One sample from American Indian patient is not considered in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.971600E-01 |
| Normal-vs-AfricanAmerican |
2.294000E-01 |
| Normal-vs-Asian |
5.432400E-01 |
| Caucasian-vs-AfricanAmerican |
9.565600E-01 |
| Caucasian-vs-Asian |
8.773400E-01 |
| AfricanAmerican-vs-Asian |
9.071800E-01 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.616600E-01 |
| Normal-vs-Female |
2.979600E-01 |
| Male-vs-Female |
2.078800E-01 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Note
Four samples from patients aged below 21 are not considered in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.946200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.714400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.192600E-01 |
| Normal-vs-Age(81-100Yrs) |
4.485600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.869400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.254200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.331400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.706200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.496000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.730400E-01 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Paraganglioma |
3.202800E-01 |
| Normal-vs-Pheochromocytoma |
2.673200E-01 |
| Normal-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
6.432600E-01 |
| Paraganglioma-vs-Pheochromocytoma |
9.904400E-01 |
| Paraganglioma-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
1.503800E-01 |
| Pheochromocytoma-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
7.362100E-02 |
|
|
